Director of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Marcus Joel S, sells 15,250 shares worth $532,683
According to Intra-Cellular Therapies, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Mar 04 05:43 PM, company Director, Marcus Joel S disclosed selling 15,250 shares at a cost of $34.93. At the time of this transaction (Mar 02), this trade was worth $532,683 in total. As of Mar 02, Marcus Joel S now owns 72,269 shares in total worth about $2,404,389.6300000004.
For the last few recent trades made by Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Director, Marcus Joel S, we have the following information:
- SEC Form 4 filing: May 14: Sold 9,602 shares at the rate of $20.04 per share. Total worth of this trade was $192,424. Total number of shares owned as of May 14 were 39,140
- SEC Form 4 filing: May 11: Sold 50,000 shares at the rate of $19.95 per share. Total worth of this trade was $997,500. Total number of shares owned as of May 11 were 48,742
- SEC Form 4 filing: May 13: Sold 7,297 shares at the rate of $20.63 per share. Total worth of this trade was $150,537. Total number of shares owned as of May 13 were 14,374
Posted by
George Daniels
on Thursday March 04 2021, 7:44 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
